Marinus Pharmaceuticals reported $-19361000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Eisai 4523:JP Y -20779M 34669M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Minerva Neurosciences NERV:US $ -9.76M 13.35M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Ptc Therapeutics PTCT:US $ -121.89M 16.72M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Supernus Pharmaceuticals SUPN:US $ 14.72M 12.67M
YTE INCY:US $ 172.84M 1.75M